Although in most patients preoperative SRLs reduce GH and IGF-1 levels, promote tumor shrinkage and soften tumor consistency (17), our results, in accordance with previous studies (18, 19), also described non-significant differences between patients pretreated and non-pretreated with fgSRL in terms of surgical remission. This evidence concerns the gene GH1 and neoplasm.